Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
Terminated
EMD Serono
Phase 4
2006-03-01
Sponsor has decided to discontinue Luveris® in the United States (US) due to level of
customer demand for this product, and not due to any efficacy or safety concerns.
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
Completed
Royal University Hospital Foundation
Phase 4
2007-02-01
The objective of the study is to elucidate the effect of synchronizing initiation of ovarian
stimulation treatment with follicular wave emergence in poor responder patients undergoing
IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle
will increase the number of follicles recruited and oocytes retrieved.
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
Completed
University of Saskatchewan
Phase 4
2007-02-01
The objective of the study is to elucidate the effect of synchronizing initiation of ovarian
stimulation treatment with follicular wave emergence in poor responder patients undergoing
IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle
will increase the number of follicles recruited and oocytes retrieved.
To study whether addition of human LH hormone (Luveris) during the final days of stimulation
with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for
patients undergoing in vitro fertilisation.
To study whether addition of human LH hormone (Luveris) during the final days of stimulation
with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for
patients undergoing in vitro fertilisation.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.